EMD Serono, Inc.

EMD Serono, a leading biopharmaceutical company, has been committed to transforming lives since its inception in 1981. With a focus on innovation and patient care, EMD Serono is dedicated to delivering cutting-edge healthcare solutions globally. As part of the Merck KGaA, Darmstadt, Germany, EMD Serono leverages its rich heritage and expertise in biotechnology to push the boundaries of medicine.

Operating from its headquarters in Rockland, Massachusetts, EMD Serono employs around 1,900 professionals who drive the company's mission to improve healthcare outcomes. Through rigorous research and development, the company focuses on addressing unmet medical needs in areas such as oncology, neurology, and immunology. Their pioneering efforts have positioned EMD Serono as a key player in the biopharmaceutical industry.

Under the leadership of CEO Belén Garijo, EMD Serono continues to expand its impact by fostering collaborations and partnerships with healthcare providers and research institutions. This commitment to excellence ensures the delivery of innovative therapies and solutions that improve the quality of life for patients worldwide. EMD Serono remains steadfast in its pursuit of scientific advancements, reinforcing its role as a leader in biopharmaceuticals.